journal article·2017-04

Design and development of sustained-release glyburide-loaded silica nanoparticles

JAYESH S PATIL, PRITAM B PATIL, PRAVIN SONAWANE, JITENDRA B NAIK

Bulletin of Materials Science· Volume 40· Issue 2
Publisher page

Abstract

The aim of this study was to develop sustained-release glyburide-loaded silica nanoparticles. Silica nanoparticles were synthesized by the sol–gel method using tetra-ethyl ortho-silane as a precursor. Glyburide was successfully entrapped in synthesized silica nanoparticles. To identify the effect of independent variables (concentration of silica and concentration of glyburide) on encapsulation efficiency and drug release (dependent variables), 32 (three level-two factors) response surface methodology was employed. Silica nanoparticles and glyburide-loaded silica nanoparticles were characterized by scanning electron microscopy, BET surface area, X-ray diffraction and Fourier transformed infrared spectroscopy. The optimum values of encapsulation efficiency and drug release were 70.21 and 87.8% over 24 h, respectively; these values agree well with predicted values obtained by response surface methodology. Glyburide-loaded silica nanoparticles were successfully prepared without any incompatibility and seem to be promising for sustained-release drug delivery application and better patient compliance.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesoporous Materials and Catalysis · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (24)

Show source-provided references
1. Kwon S, Singh R K, Perez R A, Abou Neel E A, Kim H -W and Chrzanowski W 2013 J. Tissue Eng. 4 204173141350335710.1177/2041731413503357 ↗
2. Yuan X and Cormack A 2003 J. Non-Cryst. Solids 319 3110.1016/S0022-3093(02)01960-9 ↗
3. Zhang Q, Wang X, Li P -Z et al 2014, Adv. Funct. Mater. 24 245010.1002/adfm.201302988 ↗
4. He Y and Yu X 2007 Mater. Lett. 61 207110.1016/j.matlet.2006.08.018 ↗
5. Graf C, Gao Q, Schütz I et al 2012, Langmuir 28 759810.1021/la204913t ↗
6. Ribeiro T, Baleizao C and Farinha J 2014 Materials 7 388110.3390/ma7053881 ↗
7. Zoeller T, Dressman J B and Klein S 2012 Int. J. Pharm. 430 17610.1016/j.ijpharm.2012.04.029 ↗
8. Mokale V, Patil K, Khatik T and Sutar Y 2013 Asian J. Pharmacol. 7 11110.4103/0973-8398.120085 ↗
9. Ashcroft F M 2005 J. Clin. Invest. 115 204710.1172/JCI25495 ↗
10. Inzucchi S E, Bergenstal R M, Buse J B et al 2012, Diabetes Care 35 136410.2337/dc12-0413 ↗
11. Malmberg K 1997 BMJ 314 155210.1136/bmj.314.7093.1512 ↗
12. Jonsson A, Rydberg T, Ekberg G, Hallengren B and Melander A 1994 Diabetes Care 17 14210.2337/diacare.17.2.142 ↗
13. Langer O 2002 Semin. Perinatol. 26 21510.1053/sper.2002.33960 ↗
14. Xinyue H, Neil P Y and Helen E T 2014 Nanomater. Nanotechnol. 4 110.5772/58289 ↗
15. Kalpesh S, Ana L, Daniel S, Tito T and Joao A P C 2011 Green Chem. 13 34010.1039/c0gc00690d ↗
16. Haijiao Z, Zhiyong L, Panpan X, Ruofei W and Zheng J 2010 Chem. Commun. 46 678310.1039/c0cc01673j ↗
17. Nayak A K, Pal D, Pradhan J and Hasnain M S 2013 Int. J. Biol. Macromol. 54 14410.1016/j.ijbiomac.2012.12.008 ↗
18. Pritam P, Khairnar G and Naik J 2015 Chem. Eng. Res. Des. 104 9810.1016/j.cherd.2015.07.021 ↗
19. Shanbagh P, Abhyankar M, Shah H, Kalsulkar S, Tripathi G and Belge P 2011 PHARMA Rev. 17610.5005/jp/books/11274_8 ↗
20. Yadava S K, Patil J S, Mokale V J and Naik J B 2014 J. Sol–Gel Sci. Technol. 71 6010.1007/s10971-014-3325-5 ↗
21. Deshmukh R K and Naik J B 2013 J. Pharm. Innov. 8 27610.1007/s12247-013-9167-9 ↗
22. Das S, Ng W K, Kanaujia P, Kim S and Tan R B H 2011 Colloids Surf. B Biointerfaces 88 48310.1016/j.colsurfb.2011.07.036 ↗
23. Chopra S, Patil G V and Motwani S K 2007 Eur. J. Pharm. Biopharm. 66 7310.1016/j.ejpb.2006.09.001 ↗
24. Montgomery D C 2008 Introduction to statistical quality control 4th edn (New York: Wiley)